How severe is CVE-2022-40470?

CVE-2022-40470 has a CVSS 3.x base score of 4.8, rated medium severity. It is exploitable over network with low attack complexity, requires high privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.

Is CVE-2022-40470 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (46th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-40470?

CVE-2022-40470 affects Phpgurukul Blood Donor Management System. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2022-40470?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2022-40470 published?

CVE-2022-40470 was published on 2022-11-21 and last updated on 2026-06-17.

CVE-2022-40470

CVE-2022-40470 is a medium-severity vulnerability in Phpgurukul Blood Donor Management System with a CVSS 3.x base score of 4.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Medium (CVSS 3.x base score 4.8)
EPSS exploit prediction: 1% (46th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-79
Affected product: Phpgurukul Blood Donor Management System
Published: 2022-11-21
Last modified: 2026-06-17

Description

Phpgurukul Blood Donor Management System 1.0 allows Cross Site Scripting via Add Blood Group Name Feature.

Frequently asked questions

What is CVE-2022-40470?: Phpgurukul Blood Donor Management System 1.0 allows Cross Site Scripting via Add Blood Group Name Feature.
How severe is CVE-2022-40470?: CVE-2022-40470 has a CVSS 3.x base score of 4.8, rated medium severity. It is exploitable over network with low attack complexity, requires high privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2022-40470 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (46th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-40470?: CVE-2022-40470 affects Phpgurukul Blood Donor Management System. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-40470?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2022-40470 published?: CVE-2022-40470 was published on 2022-11-21 and last updated on 2026-06-17.

References

https://drive.google.com/file/d/1UDuez2CTscdWXYzyXLi3x8CMs9IWLL11/view?usp=sharing

Affected products (1)

cpe:2.3:a:phpgurukul:blood_donor_management_system:1.0:*:*:*:*:*:*:*

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →